Background Image
Table of Contents Table of Contents
Previous Page  12 / 42 Next Page
Information
Show Menu
Previous Page 12 / 42 Next Page
Page Background

RESEARCH ARTICLE

SA JOURNAL OF DIABETES & VASCULAR DISEASE

10

VOLUME 17 NUMBER 1 • JULY 2020

Prevalence of diabetic neuropathy and risk factors for

diabetic foot ulcers among patients in a tertiary health

institution

MICHAEL ADEYEMI OLAMOYEGUN, AKINYELE TAOFIQ AKINLADE, GBADEBO OLADIMEJI AJANI,

EMMANUEAL YEMI FAGBEMIRO

Correspondence to: Michael Adeyemi Olamoyegun

Department of Medicine; Endocrinology, Diabetes & Metabolism Unit,

College of Health Sciences, Ladoke Akintola University of Technology/

LAUTECH Teaching Hospital, Ogbomoso, Oyo State, Nigeria

e-mail:

maolamoyegun@lautech.edu.ng

Akinyele Taofiq Akinlade

Department of Medicine, General Hospital, Odan, Lagos, Nigeria

Gbadebo Oladimeji Ajani

Department of Medicine, Federal Teaching Hospital, Afe Babalola University,

Ado-Ekiti, Nigeria

Emmanuel Yemi Fagbemiro

Department of Medicine, Nile University of Abuja, Nigeria

S Afr J Diabetes Vasc Dis

2020;

17

: 10–14

Abstract

Background:

Diabetic foot is one of the most devastating

chronic complications of diabetes mellitus and is usually pre-

ceded by many risk factors, including peripheral neuropathy.

An understanding of these potential risk factors enables early

recognition and modification where possible. Hence this

study aimed to assess prevalence of peripheral neuropathy

and other risk factors for the development of diabetic foot.

Methods:

This study involved adults diagnosed with type

2 diabetes who were consecutively recruited from the

LAUTECH Teaching Hospital Diabetes Clinic, Ogbomoso,

Nigeria. Participants were surveyed for the presence of

foot ulcers, skin changes, deformities, dystrophic nails

and sensory neuropathy, using a 10-g Semmes-Weinstein

monofilament, 128-Hz tuning fork, diabetic neuropathy

symptoms score and diabetic neuropathy examination score.

Results:

The mean age was 62.08 ± 8.70 years and 47.5%

were male. Diabetes duration was 4.97 ± 4.10 years. The

prevalence of active foot ulceration among the study

participants was 14.4%. Diabetic peripheral neuropathy

(DPN) was diagnosed with monofilament insensitivity in

24.5% of patients, vibration insensitivity in 19.4%, no joint

position sense in 12.2%, diabetic neuropathy examination

in 15.1% and diabetic neuropathy symptoms score in 41.0%.

We found dry skin in 24.5%, claw toes in 19.4%, dystrophic

nails in 18.7%, calluses in 11.5% and gangrene in 4.3%.

Conclusion:

There was a high prevalence of DPN in our

patients, with a significant prevalence of diabetic foot ulcer

in 14.4%. It is suggested that regular screening for DPN

should be performed, with the aim of early recognition and

prevention of factors predisposing to foot ulceration.

Keywords:

prevalence, diabetic foot, peripheral neuropathy, risk

factors

Introduction

Diabetic foot, according to the World Health Organisation (WHO)

and the International Working Group on the Diabetic Foot, is

defined as ‘the foot of diabetic patients that has the potential risk

of pathologic consequences including ulceration, infection, and/or

destruction of deep tissues associated with neurologic abnormalities,

various degrees of peripheral vascular disease, and/or metabolic

complications of diabetes in the lower limb’.

1

In many developing

countries it is a major debilitating complication with severe morbidity

and possible amputations. Individuals with diabetes have a higher

risk of amputation than non-diabetic subjects.

2-5

Foot complications are one of the most frequent reasons for

hospitalisation in diabetes, accounting for up to 25% of all

admissions.

6,7

It has been estimated that 10 to 15% of diabetic

patients will develop a foot ulcer at some point in their lifetimes,

8-10

and that the risk of lower-extremity amputation is 15 to 40 times

higher in people with diabetes than in those without diabetes.

11

Up to 85% of foot amputations are preventable.

12

Foot ulcers

have been reported in a Nigerian population to occur after a mean

interval of 13 years from the diagnosis of diabetes.

13

Hospital-based studies demonstrated that the prevalence of limb

ulcerations in Nigeria was between 11.7 and 19.1%.

14,15

In Nigeria,

no sufficient data exist to help recognise the magnitude of the

risks for diabetic foot. A Nigerian study by Adigun and Olarinoye

examined the characteristics of patients with diabetic foot ulcers

attending an out-patient clinic at the University of Ilorin teaching

hospital. The investigator examined 105 diabetic patients, with a

mean age of 54 years, and found the prevalence of diabetic foot

ulceration to be 29.5%, callus 5.7% and cracked skin 11.4%.

16

Because of the high burden of diabetic foot ulceration and its

sequelae, identification of patients at risk for foot ulceration is of

paramount importance. This is because early detection with the

initiation of effective treatment has been shown to reduce the

prevalence of diabetic foot ulcerations and lesions by 44 to 85%.

17,18

Therefore, targeting patients at increased risk for developing foot

ulcers is believed to constitute a cost-effective strategy to control

progression to foot ulceration and amputation.

Diabetic peripheral neuropathy (DPN), which is defined as the

presence of symptoms and/or signs of peripheral nerve dysfunction

in patients with diabetes after exclusion of other causes,

19

is an

independent risk factor for foot ulceration and lower-extremity

amputation. It often presents with a loss of sensation on the foot

(sensory deficit), which can cause a patient to sustain an injury

without recognising any inciting trauma.

19

While the gold standard for diagnosis of DPN continues to be

a nerve conduction study (NCS), it is time consuming, requires a

separate patient visit and is costly. This cumbersome procedure